• Go to navigation
  • Go to content
AstraZeneca Austria

Astrazeneca Worldwide

  • AstraZeneca websites
AstraZeneca

title

  • Willkommen
  • Wir über uns
  • News
    • Nachrichten
    • Medical News
    • Pressemitteilungen
    • Corporate Press Releases
  • Jobs & Karriere
  • Gesundheit interessiert ALLE
  • Für Fachkreise
  • Arzneimittelsicherheit
  • SiteMap
  • Kontakt

You are here

  • Willkommen
  • News
  • Nachrichten

Nachrichten aus der Welt der Medizin. Zur Verfügung gestellen von CMG (Current Medicine Group).
  • Seiten
  • Zurück
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • Weiter

Date

    • 27.08.2010
    • Leptin: adiponectin ratio not best marker of atherosclerosis susceptibility   The ratio of leptin to adioponectin should not be preferentially used as a marker of atherosclerosis susceptibility, according to the results of a Dutch study.
    • 27.08.2010
    • Multiple socioeconomic disadvantages linked with midlife metabolic syndrome   Several signs of socioeconomic disadvantage during adulthood are associated with an increased risk for the metabolic syndrome in middle age, suggests a study of men who served in the US military at the time of the Vietnam War.
    • 27.08.2010
    • Obese men should have prostate cancer screen adjusted for BMI   Overweight and obese men may have diminished prostate cancer detection owing to low prostate-specific antigen levels, report US researchers who recommend adjusting prostate cancer screening to allow for the impact of body mass index.
    • 27.08.2010
    • Routine use of pharmacogenetic warfarin dosing algorithms unjustified   The accuracy of pharmacogenetic warfarin dosing algorithms does not support the routine, prospective use of genetically-guided dosing in patients starting therapy with the anticoagulant, study findings indicate.
    • 27.08.2010
    • Same-day discharge ‘safe’ for elective PCI patients   Same-day discharge of patients undergoing uncomplicated elective percutaneous coronary intervention is feasible, suggest US researchers.
  • Seiten
  • Zurück
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • Weiter

Sie sind nicht angemeldet.



  • Passwort vergessen

Service

  • Druckversion
  • Website zu Favoriten hinzufügen

Legal notices

  • Rechtliche Hinweise
  • Impressum
  • AGB
  • Hinweise für externe Dienstleister
  • © AstraZeneca 2010